Search Results - "Nakase, Masaaki"

Diuretic and renal effects of angiotensin receptor-neprilysin inhibitor in patients hospitalized for acute heart failure by Setoguchi, Naoto, Horiuchi, Yu, Kawakami, Toshiharu, Nakase, Masaaki, Watanabe, Yusuke, Ishizawa, Taiki, Sekiguchi, Masahiro, Nakajima, Momoka, Nonaka, Hideaki, Asami, Masahiko, Yahagi, Kazuyuki, Komiyama, Kota, Yuzawa, Hitomi, Tanaka, Jun, Aoki, Jiro, Tanabe, Kengo

“…In patients hospitalized for acute decompensation of heart failure (HF), the impact of angiotensin receptor-neprilysin inhibitor (ARNI) on diuresis and renal…”
Get full text

Malnutrition, hemodynamics and inflammation in heart failure with reduced, mildly reduced and preserved ejection fraction by Watanabe, Yusuke, Horiuchi, Yu, Nakase, Masaaki, Setoguchi, Naoto, Ishizawa, Taiki, Sekiguchi, Masahiro, Nonaka, Hideaki, Nakajima, Momoka, Asami, Masahiko, Yahagi, Kazuyuki, Komiyama, Kota, Yuzawa, Hitomi, Tanaka, Jun, Aoki, Jiro, Tanabe, Kengo

“…In patients with heart failure (HF) with reduced ejection fraction (HFrEF), malnutrition can be associated with intestinal congestion and systemic…”
Get full text

Acute Myocarditis in a Patient Following mRNA-1273 SARS-CoV-2 Vaccination by Kawakami, Toshinaru, Yahagi, Kazuyuki, Sekiguchi, Masahiro, Ishizawa, Taiki, Nonaka, Hideaki, Setoguchi, Naoto, Watanabe, Yusuke, Nakase, Masaaki, Horiuchi, Yu, Asami, Masahiko, Yuzawa, Hitomi, Komiyama, Kota, Tanaka, Jun, Aoki, Jiro, Tanabe, Kengo

“…We herein report a case of acute myocarditis possibly related to the second dose of an mRNA-coronavirus disease 2019 vaccine in a 45-year-old woman with no…”
Get full text

Effect of dapagliflozin on ventricular repolarization in patients with heart failure with reduced ejection fraction by Nakase, Masaaki, Yahagi, Kazuyuki, Horiuchi, Yu, Asami, Masahiko, Yuzawa, Hitomi, Komiyama, Kota, Tanaka, Jun, Aoki, Jiro, Tanabe, Kengo

“…Whether sodium–glucose cotransporter-2 inhibitors (SGLT2is) reduce ventricular arrhythmias and sudden cardiac death is controversial. Ventricular…”
Get full text

Impact of Dapagliflozin on the Renal Function and Damage in Patients with Heart Failure with a Reduced Ejection Fraction by Nakase, Masaaki, Ninomiya, Kai, Horiuchi, Yu, Sekiguchi, Masahiro, Watanabe, Yusuke, Setoguchi, Naoto, Asami, Masahiko, Yahagi, Kazuyuki, Yuzawa, Hitomi, Komiyama, Kota, Tanaka, Jun, Aoki, Jiro, Tanabe, Kengo

“…Objective Whether or not the initial dip in the glomerular filtration rate (GFR) after the initiation of sodium-glucose co-transporter 2 inhibitors (SGLT2is)…”
Get full text

Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement by Tomii, Daijiro, Heg, Dik, Lanz, Jonas, Nakase, Masaaki, Samim, Daryoush, Stortecky, Stefan, Reineke, David, Windecker, Stephan, Pilgrim, Thomas

“…Periprocedural myocardial injury impacts clinical outcome after transcatheter aortic valve replacement (TAVR). The optimal medical management strategy for…”
Get full text

The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fraction by Tomii, Daijiro, Horiuchi, Yu, Gonda, Yuki, Yoshiura, Daiki, Nakajima, Momoka, Sekiguchi, Masahiro, Watanabe, Yusuke, Nakamura, Kosuke, Setoguchi, Naoto, Nakase, Masaaki, Kikushima, Hosei, Ninomiya, Kai, Tanaka, Tetsu, Asami, Masahiko, Yahagi, Kazuyuki, Yuzawa, Hitomi, Komiyama, Kota, Tanaka, Jun, Aoki, Jiro, Tanabe, Kengo

“…•The renal resistance index (RRI) was correlated with tricuspid regurgitation peak gradient in heart failure with preserved ejection fraction (HFpEF) and pulse…”
Get full text

Delayed rupture of the iliac artery after endovascular therapy by Nakase, Masaaki, Yahagi, Kazuyuki, Komiyama, Kota, Nemoto, Shuhei, Kawabe, Akihiro, Hosoda, Naoki, Horiuchi, Yu, Asami, Masahiko, Yuzawa, Hitomi, Tanaka, Jun, Aoki, Jiro, Mori, Masaya, Tanabe, Kengo

“…Iliac artery rupture during endovascular therapy (EVT) is a life-threatening complication requiring prompt diagnosis and treatment. However, delayed rupture of…”
Get full text

Anticoagulant management during percutaneous coronary intervention for a patient with antithrombin deficiency by Kitamura, Shun, Komiyama, Kota, Yahagi, Kazuyuki, Sekiguchi, Masahiro, Ishizawa, Taiki, Nonaka, Hideaki, Nakase, Masaaki, Horiuchi, Yu, Asami, Masahiko, Yuzawa, Hitomi, Tanaka, Jun, Aoki, Jiro, Tanabe, Kengo

“…Previous reports on cardiac intervention in cases with antithrombin deficiency are extremely limited. We report a case of acute coronary syndrome with…”
Get full text

Combined Significant Aortic Stenosis and Mitral Regurgitation: Challenges in Timing and Type of Intervention by Alaour, Bashir, Nakase, Masaaki, Pilgrim, Thomas

“…In this narrative review, we aim to summarize the literature surrounding the assessment and management of the common, yet understudied combination of aortic…”
Get full text

TCT-54 Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement by Tomii, Daijiro, Okuno, Taishi, Nakase, Masaaki, Praz, Fabien, Stortecky, Stefan, Windecker, Stephan, Lanz, Jonas, Pilgrim, Thomas

Get full text

Large-bore sheath insertion using a slip-through technique in transcatheter aortic valve replacement by Nakase, Masaaki, Asami, Masahiko, Miura, Sumio, Yokozuka, Motoi, Tanabe, Kengo

Get full text

Large-bore sheath insertion using a slip-through technique in transcatheter aortic valve replacement by Nakase, Masaaki, Asami, Masahiko, Miura, Sumio, Yokozuka, Motoi, Tanabe, Kengo

Get full text

Relationship of Upstream Cardiac Damage With Myocardial Injury in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Implantation by Nakase, Masaaki, Tomii, Daijiro, Stortecky, Stefan, Lanz, Jonas, Windecker, Stephan, Pilgrim, Thomas

Get full text

Safety and Efficacy of Balloon-Expandable Transcatheter Aortic Valve Implantation in Patients With Extreme Horizontal Aorta by Nakase, Masaaki, Tomii, Daijiro, Praz, Fabien, Stortecky, Stefan, Lanz, Jonas, Reineke, David, Windecker, Stephan, Pilgrim, Thomas

Get full text

Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR by Nakase, Masaaki, Tomii, Daijiro, Samim, Daryoush, Gräni, Christoph, Praz, Fabien, Lanz, Jonas, Stortecky, Stefan, Reineke, David, Windecker, Stephan, Pilgrim, Thomas

“…Vascular complications remain a major concern in transfemoral transcatheter aortic valve replacement (TAVR). The Hostile score has been proposed to stratify…”
Get full text

Long-Term Impact of Cardiac Damage Following Transcatheter Aortic Valve Replacement by Nakase, Masaaki, Tomii, Daijiro, Heg, Dik, Praz, Fabien, Stortecky, Stefan, Reineke, David, Samim, Daryoush, Lanz, Jonas, Windecker, Stephan, Pilgrim, Thomas

“…Extravalvular cardiac damage caused by aortic stenosis affects prognosis after transcatheter aortic valve replacement (TAVR). The long-term impact of changes…”
Get full text

Sex-Specific Differences in Upstream Cardiac Damage in Patients With Aortic Stenosis Undergoing TAVR by Nakase, Masaaki, Tomii, Daijiro, Maznyczka, Annette, Samim, Daryoush, Lanz, Jonas, Praz, Fabien, Stortecky, Stefan, Reineke, David, Windecker, Stephan, Pilgrim, Thomas

“…Cardiac damage caused by aortic stenosis (AS) can be categorized into stages, which are associated with a progressively increasing risk of death after…”
Get full text

Five-Year Outcomes with Self-expanding versus Balloon-expandable TAVI in Patients with Left Ventricular Systolic Dysfunction by Nakase, Masaaki, Tomii, Daijiro, Maznyczka, Annette, Heg, Dik, Okuno, Taishi, Samim, Daryoush, Stortecky, Stefan, Lanz, Jonas, Reineke, David, Windecker, Stephan, Pilgrim, Thomas

“…The importance of transcatheter heart valve (THV) design on clinical outcome in patients with aortic stenosis (AS) and left ventricular (LV) systolic…”
Get full text

Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement by Tomii, Daijiro, Okuno, Taishi, Nakase, Masaaki, Praz, Fabien, Stortecky, Stefan, Reineke, David, Windecker, Stephan, Lanz, Jonas, Pilgrim, Thomas

“…The optimal medical treatment strategy after transcatheter aortic valve replacement (TAVR) has not been established, and might be affected by the extent of…”
Get full text